Dynavax to Present at the 34th Annual Cowen & Company Health Care Conference
February 28 2014 - 4:00PM
Marketwired
Dynavax to Present at the 34th Annual Cowen & Company Health
Care Conference
BERKELEY, CA--(Marketwired - Feb 28, 2014) - Dynavax
Technologies Corporation (NASDAQ: DVAX) announced today that it
will present at the 34th Annual Cowen & Company Health Care
Conference in Boston on Tuesday, March 4, 2014 at 10:00 a.m.
Eastern Time (7:00 a.m. Pacific Time).
Eddie Gray, Chief Executive Officer of Dynavax, will provide a
company overview. To access the slide presentation, live webcast,
and subsequent archived recording, please visit Dynavax's website
at http://investors.dynavax.com/newsevents.cfm.
About Dynavax Dynavax, a clinical-stage
biopharmaceutical company, discovers and develops novel vaccines
and therapeutics in the areas of infectious and inflammatory
diseases and oncology. Dynavax's lead product candidate is
HEPLISAV-B, a Phase 3 investigational adult hepatitis B vaccine.
For more information visit www.dynavax.com.
Contact: Michael Ostrach Vice President and Chief Business
Officer 510-665-7257 Email Contact
Dynavax Technologies (NASDAQ:DVAX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Dynavax Technologies (NASDAQ:DVAX)
Historical Stock Chart
From Apr 2023 to Apr 2024